News | February 09, 2009

Two Trials Find Hyperthermia Therapy Help in Treating Cervical Cancer

February 9, 2009 - BSD Medical provided a translated version of a press release issued by the German Cancer Society entitled, "Putting the heat on advanced cervical cancer." The translated text of this important press release is as follows:

Two trials have documented good rates of therapy success with the combination of radiotherapy (radiation therapy) and deep hyperthermia for treating advanced cervical cancer. One treatment option for advanced cervical cancer is radiotherapy in combination with chemotherapy. Chemotherapy, however, is not possible for all patients due to health and other reasons. Also, if a tumor has already spread beyond the cervix and penetrated surrounding tissue or parts of the vagina, it is often impossible to eliminate the tumor permanently using radiotherapy alone. In these cases, combining radiotherapy with deep hyperthermia can produce better results.

The most recent data from two trials published in the International Journal of Radiation Oncology*Biology*Physics have shown that tumor growth can be better controlled and survival rates increased using a combination therapy.

Cancerous cells are more sensitive to heat than are healthy cells – a fact that is exploited in hyperthermia therapy.

Temperatures of 42 to 43 degrees Celsius are sufficient to kill a large portion of the cells. Additionally, the heating of tumor tissue produces heat shock proteins that activate the immune system to fight the cancerous cells. Hyperthermia is not used as the sole treatment method for cancer, rather as a complement to chemo- or radiotherapy.

Deep hyperthermia is appropriate for treating tumors located deep inside the patient's body. The heat is generated using electromagnetic RF waves. Using computer technology, the heat is targeted at the cancer focus, affecting the surrounding healthy tissue as little as possible.

In the two trials recently published by Dutch researchers, it was documented that a combination therapy consisting of radiotherapy and deep hyperthermia yielded good results with advanced cervical cancer.

Patients participating in the trial were women with cancer that was either locally advanced or had already spread to the lymph nodes, other organs in the pelvic area, and organs adjacent to the pelvic area (stages II through IVA). Compared to radiotherapy alone, combining radiotherapy and deep hyperthermia produced improvements in response rates and tumor control. Furthermore, long-term survival rates improved.

The researchers recommend offering the option of combined radiotherapy and deep hyperthermia to patients who cannot undergo chemotherapy. In Dutch radiotherapy centers, the combined therapy is already standard practice. In Germany so far, this treatment option is only offered in specialized centers.

For more information about hyperthermia and hyperthermia centers in Germany, visit the Web site of the interdisciplinary hyperthermia workgroup of the Deutsche Krebsgesellschaft:

For more information:,

Related Content

Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...
RaySearch Launches RayCare Oncology Information System

Image courtesy of RaySearch Laboratories

Technology | Oncology Information Management Systems (OIMS) | December 22, 2017
RaySearch announced the first release of RayCare, a new oncology information system (OIS) designed to connect the...
RaySearch Releases RayStation 7 Radiotherapy Treatment Planning System
Technology | Treatment Planning | December 19, 2017
RayStation 7, the latest release of RaySearch’s radiation therapy treatment planning system, adds new functionality and...
Overlay Init